Advertisement
Screener

Biomea Fusion, Inc. (BMEA) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Biomea Fusion, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Biomea Fusion, Inc. price/book ratio for the quarter ending 2026-06-30 was 8.84, a 131.11% increase year-over-year.
  • Biomea Fusion, Inc. price/book ratio for the quarter ending 2026-03-31 was 5.83, a 109.42% increase year-over-year.
  • Biomea Fusion, Inc. price/book ratio for the quarter ending 2025-12-31 was 3.01, a 10.16% increase year-over-year.
  • Biomea Fusion, Inc. price/book ratio for the quarter ending 2025-09-30 was 7.73, a 60.54% increase year-over-year.
  • Biomea Fusion, Inc. price/book ratio for fiscal 2026 was 8.84.
  • Biomea Fusion, Inc. price/book ratio for fiscal 2025 was 3.01, a 10.16% increase from fiscal 2024.
  • Biomea Fusion, Inc. price/book ratio for fiscal 2024 was 2.73, a 11.23% decline from fiscal 2023.
  • Biomea Fusion, Inc. price/book ratio for fiscal 2023 was 3.08, a 34.03% increase from fiscal 2022.
Available history
2021-06-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-308.84$107.28M$12.14M
2026-03-315.83$109.17M$18.72M
2025-12-313.01$88.93M$29.55M
2025-09-307.73$120.8M$15.62M
2025-06-303.82$105.21M$27.51M
2025-03-312.78$80.03M$28.74M
2024-12-312.73$140.89M$51.57M
2024-09-304.82$366.01M$75.97M
2024-06-301.57$162.83M$103.95M
2024-03-313.97$537.21M$135.31M
2023-12-313.08$520.78M$169.24M
2023-09-302.46$491.22M$199.61M
2023-06-303.49$782.08M$224.31M
2023-03-3111.06$919.48M$83.13M
2022-12-312.3$249.2M$108.54M
2022-09-302.2$287.42M$130.64M
2022-06-302.33$350.78M$150.39M
2022-03-310.79$130.09M$164.77M
2021-12-311.21$216.91M$178.78M
2021-09-301.82$347.63M$191.33M
2021-06-302.24$452.54M$202.02M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-308.84$107.28M$12.14M
2025-12-313.01$88.93M$29.55M
2024-12-312.73$140.89M$51.57M
2023-12-313.08$520.78M$169.24M
2022-12-312.3$249.2M$108.54M
2021-12-311.21$216.91M$178.78M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
ProMIS Neurosciences Inc. (PMN)$0.102B
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B